VBIO · Company research
Valion Bio, Inc. Common Stock (VBIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Valion Bio, Inc. (VBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada | Valion Bio, Inc. (VBIO) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| A new system showed a strong link to a cell-growth measure during fermentation. Valion Bio plans further development. - Stock Titan | A new system showed a strong link to a cell-growth measure during fermentation. Valion Bio plans further development. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Some patented drug imports face taxes up to 100%. Valion offers U.S. biologic production. - Stock Titan | Some patented drug imports face taxes up to 100%. Valion offers U.S. biologic production. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Valion Bio, Inc. (VBIO) Stock Price & News - Syfe | Valion Bio, Inc. (VBIO) Stock Price & News Syfe | View source ↗ | Syfe | Oct 13, 2026 | neutral | 0 | 0.6 |
| A potential radiation drug could be absorbed through the mouth instead of injected. - Stock Titan | A potential radiation drug could be absorbed through the mouth instead of injected. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Valion Bio Secures Additional Series B Preferred Financing - The Globe and Mail | Valion Bio Secures Additional Series B Preferred Financing The Globe and Mail | View source ↗ | The Globe and Mail | Oct 9, 2026 | neutral | 0 | 0.6 |
| Up to $5M in stock is included in Valion Bio (NASDAQ: VBIO)'s proposed securities offering. - Stock Titan | Up to $5M in stock is included in Valion Bio (NASDAQ: VBIO)'s proposed securities offering. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| About $35.6 million in U.S. funding supports Valion's experimental drug for radiation sickness - Stock Titan | About $35.6 million in U.S. funding supports Valion's experimental drug for radiation sickness Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| VBIO rises after Valion Bio highlights oral Entolimod formulation milestone - Quiver Quantitative | VBIO rises after Valion Bio highlights oral Entolimod formulation milestone Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 30, 2026 | neutral | 0 | 0.6 |
| VBIO Stock Jumps As Valion Bio Resets Leadership, Regains Nasdaq Compliance - StocksToTrade | VBIO Stock Jumps As Valion Bio Resets Leadership, Regains Nasdaq Compliance StocksToTrade | View source ↗ | StocksToTrade | Sep 30, 2026 | neutral | 0 | 0.6 |
| VBIO Stock Jumps As Valion Bio Resets Leadership And Stabilizes Listing - StocksToTrade | VBIO Stock Jumps As Valion Bio Resets Leadership And Stabilizes Listing StocksToTrade | View source ↗ | StocksToTrade | Sep 30, 2026 | neutral | 0 | 0.6 |
| VBIO Stock Whipsaws As Valion Bio Resets Leadership And Stabilizes Listing - Timothy Sykes | VBIO Stock Whipsaws As Valion Bio Resets Leadership And Stabilizes Listing Timothy Sykes | View source ↗ | Timothy Sykes | Sep 30, 2026 | neutral | 0 | 0.6 |
| Valion Bio's shares met Nasdaq's $1 minimum. The listing matter is closed. - Stock Titan | Valion Bio's shares met Nasdaq's $1 minimum. The listing matter is closed. Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Valion Bio Announces Reverse Stock Split - Yahoo Finance | Valion Bio Announces Reverse Stock Split Yahoo Finance | View source ↗ | Yahoo Finance | Aug 27, 2026 | neutral | 0 | 0.6 |
| Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall - Yahoo Finance | Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall Yahoo Finance | View source ↗ | Yahoo Finance | Aug 12, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Apr 29, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.